Search

Your search keyword '"van den Berg, Anke"' showing total 1,053 results

Search Constraints

Start Over You searched for: Author "van den Berg, Anke" Remove constraint Author: "van den Berg, Anke"
1,053 results on '"van den Berg, Anke"'

Search Results

4. Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA

8. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

9. Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP

10. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

13. Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

15. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

17. Abstracts from the 3rd Conference on Aneuploidy and Cancer: Clinical and Experimental Aspects

18. Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

22. Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.

24. Inhibition of the glutamate-cysteine ligase catalytic subunit with buthionine sulfoximine enhances the cytotoxic effect of doxorubicin and cyclophosphamide in Burkitt lymphoma cells

27. CRISPR/Cas9 screen for genome‐wide interrogation of essential MYC‐bound E‐boxes in cancer cells

30. Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics

35. Data from A Novel Risk Locus at 6p21.3 for Epstein–Barr Virus-Positive Hodgkin Lymphoma

38. Supplementary Tables S1- S6 and Supplementary Figure S1 from A Novel Risk Locus at 6p21.3 for Epstein–Barr Virus-Positive Hodgkin Lymphoma

45. Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers

46. Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

47. Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma

49. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

50. Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Catalog

Books, media, physical & digital resources